“Atopic Dermatitis Disease Biomarkers Strongly Correlate With IL-13 Levels, Are Regulated by IL-13, and Are Modulated by Tralokinumab in Vitro”. SKIN The Journal of Cutaneous Medicine 3 (November 9, 2019): S42. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/770.